Articles dans des revues avec comité de lecture (9)
  1. 1. Andreozzi, F., Massaro, F., Wittnebel, S., Spilleboudt, C., Lewalle, P., & Salaroli, A. (2022). New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy. International journal of molecular sciences, 23(7), 3887. doi:10.3390/ijms23073887
  2. 2. Goudsmit, A., Cubilier, E., Meert, A.-P., Aftimos, P., Stathopoulos, K., Spilleboudt, C., & Loizidou, A. (2021). Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study. Supportive care in cancer, 29(11), 6271-6278. doi:10.1007/s00520-021-06175-z
  3. 3. Lifrange, F., de Wind, R., Spilleboudt, C., Karfis, I., Van Gossum, A., & Demetter, P. (2021). Mantle cell lymphoma simulating inflammatory bowel disease. Acta Gastro-Enterologica Belgica (English ed.), 84(1), 125-127. doi:10.51821/84.1.852
  4. 4. Spilleboudt, C., De Wilde, V., Lewalle, P., Cabanne, L., Leclerc, M., Beckerich, F., Bories, D., Cardoso, S., Soares, M. P., Vokaer, B., Hougardy, J.-M., Flamand, V., Racapé, J., Abramowicz, M., Maury, S., & Le Moine, A. (2020). Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease. Frontiers in immunology, 11, 579151. doi:10.3389/fimmu.2020.579151
  5. 5. Golstein, S., Muylle, K., Vercruyssen, M., Spilleboudt, C., de Wind, A., & Bron, D. (2018). Long-term follow-up of 2 patients treated with 90Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma. European journal of haematology, 101(3), 415-417. doi:10.1111/ejh.13087
  6. 6. Spilleboudt, C., Thibaut, P., Varlet, É. E., & Bron, D. (2018). Hyperleucocytose maligne ou bénigne? Revue médicale de Bruxelles, 39(4), 291-295.
  7. 7. Pistone, A., Maerevoet, M., Wittnebel, S., Vercruyssen, M., Spilleboudt, C., Buntinx, S., Bron, D., & Meuleman, N. (2016). Early Discontinuation of Lenalidomide in Patients with Relapsing or Refractory Multiple Myeloma: Predictive Factors for Stopping in the Real Life. Blood, 128(22), 4504-4504. doi:10.1182/blood.V128.22.4504.4504
  8. 8. Vokaer, B., Charbonnier, L.-M., Lemaitre, P., Spilleboudt, C., & Le Moine, A. (2013). IL-17A and IL-2-Expanded Regulatory T Cells Cooperate to Inhibit Th1-Mediated Rejection of MHC II Disparate Skin Grafts. PloS one, 8(10), e76040. doi:10.1371/journal.pone.0076040
  9. 9. Sadis, C., Detienne, S., Vokaer, B., Charbonnier, L.-M., Lemaitre, P., Spilleboudt, C., Delbauve, S., Kubjak, C., Flamand, V., Field, K. A., Goldman, M., Benghiat, F., & Le Moine, A. (2013). The Cholinergic Anti-Inflammatory Pathway Delays TLR-Induced Skin Allograft Rejection in Mice: Cholinergic Pathway Modulates Alloreactivity. PloS one, 8(11), e79984. doi:10.1371/journal.pone.0079984
    10.   Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (1)
  10. 1. Halkes, C. J. M., de Wreede, L. L., Knol, C., Simand, C., Aljurf, M., Tbakhi, A., Vazquez, L., Bloor, A., Wagner-Drouet, E., Vural, F., Bodova, I., Isaksson, C., Diaz, M. Á., Gruhn, B., Snowden, J. J., Arat, M., Bazarbachi, A., Spilleboudt, C., Kulagin, A., Marsh, J., Passweg, J., Risitano, A. M., Peffault de Latour, R., & Dufour, C. (2019). Allogeneic stem cell transplantation for acquired pure red cell aplasia. American journal of hematology, 94(11), E294-E296. doi:10.1002/ajh.25609
    11.   Participations à des congrès et colloques internationaux (1)
  11. 1. De Wilde, V., Spilleboudt, C., Racapé, J., Lewalle, P., Bron, D., Cohen, J., Maury, S., Abramowicz, M., & Le Moine, A. (2014). Long (GT)n repeat in the promoter region of heme oxygenase-1 is associated with severe graft-versus-host disease. Poster présenté à la conférence 29th General Annual Meeting Belgian Hematological Society (29: 2014).